Psoriasis Reference Articles, Studies and Research

 

"Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg/g ointment and calcipotriol 50 microg/g ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas." British Journal of Dermatology - 2003 Feb;148(2):326-33. Ortonne JP, Humbert P, Nicolas JF, Tsankov N, Tonev SD, Janin A, Czernielewski J, Lahfa M, Dubertret L.

 

"The safety of calcitriol 3 mg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photo allergic contact sensitization and phototoxicity" - European Journal of Dermatology - Vol 11, Issue 3 - May-June 2001 - By Catherine Queilleroussel, Luc Duteil, Anne Parneix-Spake, Stephanie Arsonnaud, Elena Rizova

 

US FDA Approval for Calcitriol..
Calcitriol has been in European market for several year, US FDA has recently approved Calcitriol based topical formulations for Psoriasis.

 

"Novel topical therapy for mild-to-moderate plaque psoriasis: focus on calcitriol" - Clinical, Cosmetic and Investigational Dermatology 15 September 2009 - Lutz Kowalzick Department of Dermatology and Allergology, HeLIOS vogtland-Klinikum Plauen GmbH Plauen, Germany

 

"Vitamin D3 metabolites and analogues in the treatment of scalp psoriasis" - Journal of Dermatological Treatment, Volume 9, Issue S3 1998 , pages S41 - S45 - A. Langner; W. Stapr; M. Ambroziak

 

"Efficacy and safety of topical calcitriol 3 [micro]g/g ointment, a new topical therapy for chronic plaque psoriasis"  - Journal of Drugs in Dermatology, 2009

 

"Calcitriol 3 [micro]g/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy" - Journal of Drugs in Dermatology 2009